Sulfuric Acid

Sulfuric Acid

SCHEMBL1767554

CCCn1cc[n+](CCC)c1C.CCCn1cc[n+](CCC)c1C.O=S(=O)([O-])[O-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.48
CA2 P00918 8/20 0.48
EEF2K O00418 2/20 0.41
EEF2 P13639 2/20 0.41
MEN1 O00255 1/20 0.41
PLK4 O00444 1/20 0.41
JAK2 O60674 1/20 0.41
EGFR P00533 1/20 0.41
TYK2 P29597 1/20 0.41
FLT3 P36888 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
ITK Q08881 1/20 0.41
PIM2 Q9P1W9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281906 0.89 CA1 (0.56) CA1CA2EEF2KEEF2MEN1
Bromide SCHEMBL1767858 0.88 CA1 (0.58) CA1CA2EEF2KEEF2MEN1
Formic Acid SCHEMBL1767512 0.87 CA1 (0.48) CA1CA2EEF2KEEF2MEN1
SCHEMBL5287167 0.79 CA1 (0.61) CA1CA2EEF2KEEF2MEN1
SCHEMBL5287162 0.79 CA1 (0.66) CA1CA2EEF2KEEF2MEN1
SCHEMBL487095 0.78 CA1 (0.51) CA1CA2EEF2KEEF2MEN1
SCHEMBL487096 0.78 CA1 (0.50) CA1CA2EEF2KEEF2MEN1
SCHEMBL5285519 0.77 CA1 (0.73) CA1CA2EEF2KEEF2MEN1
SCHEMBL5285521 0.77 CA1 (0.64) CA1CA2EEF2KEEF2MEN1
SCHEMBL5303301 0.76 CA1 (0.77) CA1CA2EEF2KEEF2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519013-B2 Method for producing formic acid Nakahara, Masaru (JP) 2013-08-27 US disclosed
EP-2319799-B1 PROCESS FOR PRODUCTION OF HYDROGEN NAKAHARA MASARU (JP) 2013-08-14 EP disclosed
US-8449862-B2 Method for producing hydrogen MASARU NAKAHARA (JP) 2013-05-28 US disclosed
EP-2530066-A1 METHOD FOR PRODUCING FORMIC ACID Nakahara, Masaru (JP) 2012-12-05 EP disclosed
US-20120295991-A1 METHOD FOR PRODUCING FORMIC ACID Nakahara, Masaru (JP) 2012-11-22 US disclosed
US-20110158899-A1 METHOD FOR PRODUCING HYDROGEN MASARU NAKAHARA (JP) 2011-06-30 US disclosed
EP-2319799-A1 PROCESS FOR PRODUCTION OF HYDROGEN Nakahara, Masaru (JP) 2011-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295991-A1 METHOD FOR PRODUCING FORMIC ACID CA3, CA1, HAO2 CA1 2/4885CA2 18/4885EEF2K 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.